Related references
Note: Only part of the references are listed.Effects of Flavonoids and other Polyphenols on Inflammation
R. Gonzalez et al.
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2011)
Novel synthetic small-molecule activators of AMPK as enhancers of autophagy and amyloid-beta peptide degradation
Valerie Vingtdeux et al.
FASEB JOURNAL (2011)
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease
Adam C. Naj et al.
NATURE GENETICS (2011)
AMP-Activated Protein Kinase-Deficient Mice Are Resistant to the Metabolic Effects of Resveratrol
Jee-Hyun Um et al.
DIABETES (2010)
Anti-inflammatory activities of resveratrol in the brain: Role of resveratrol in microglial activation
Feng Zhang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
AMP-activated Protein Kinase Signaling Activation by Resveratrol Modulates Amyloid-β Peptide Metabolism
Valerie Vingtdeux et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
SRT1720, SRT2183, SRT1460, and Resveratrol Are Not Direct Activators of SIRT1
Michelle Pacholec et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
The myeloid cells of the central nervous system parenchyma
Richard M. Ransohoff et al.
NATURE (2010)
Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease
Martin Fuhrmann et al.
NATURE NEUROSCIENCE (2010)
Classification and basic pathology of Alzheimer disease
Charles Duyckaerts et al.
ACTA NEUROPATHOLOGICA (2009)
Heterogeneity in Red Wine Polyphenolic Contents Differentially Influences Alzheimer's Disease-type Neuropathology and Cognitive Deterioration
Lap Ho et al.
JOURNAL OF ALZHEIMERS DISEASE (2009)
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease
Jean-Charles Lambert et al.
NATURE GENETICS (2009)
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
Denise Harold et al.
NATURE GENETICS (2009)
Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease
Saravanan S. Karuppagounder et al.
NEUROCHEMISTRY INTERNATIONAL (2009)
Therapeutic potential of resveratrol in Alzheimer's disease
Valerie Vingtdeux et al.
BMC NEUROSCIENCE (2008)
SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1 - Possible role in AMP-activated protein kinase activation
Fan Lan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase
Xiuyun Hou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Dynamics of the microglial/amyloid interaction indicate a role in plaque maintenance
Tristan Bolmont et al.
JOURNAL OF NEUROSCIENCE (2008)
Luteolin suppresses inflammation-associated gene expression by blocking NF-κB and AP-1 activation pathway in mouse alveolar macrophages
Chiu-Yuan Chen et al.
LIFE SCIENCES (2007)
Signaling to NF-κB by Toll-like receptors
Taro Kawai et al.
TRENDS IN MOLECULAR MEDICINE (2007)
Microglia: active sensor and versatile effector cells in the normal and pathologic brain
Uwe-Karsten Hanisch et al.
NATURE NEUROSCIENCE (2007)
Butein, a tetrahydroxychalcone, inhibits nuclear factor (NF)-κB and NF-κB-regulated gene expression through direct inhibition of IκBα kinase β on cysteine 179 residue
Manoj K. Pandey et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Gossypin, a pentahydroxy glucosyl flavone, inhibits the transforming growth factor beta-activated kinase-1-mediated NF-κB activation pathway, leading to potentiation of apoptosis, suppression of invasion, and abrogation of osteoclastogenesis
Ajaikurnar B. Kunnurnakkara et al.
BLOOD (2007)
Fisetin, an inhibitor of cyclin-dependent kinase 6, down-regulates nuclear factor-κB-regulated cell proliferation, antiapoptotic and metastatic gene products through the suppression of TAK-1 and receptor-interacting protein-regulated IκBα kinase activation
Bokyung Sung et al.
MOLECULAR PHARMACOLOGY (2007)
Resveratrol stimulates AMP kinase activity in neurons
Biplab Dasgupta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Morin (3,5,7,2′,4′-pentahydroxyflavone) abolishes nuclear factor-κB activation induced by various carcinogens and inflammatory stimuli, leading to suppression of nuclear Factor-κB-regulated gene expression and up-regulation of apoptosis
Sunil K. Manna et al.
CLINICAL CANCER RESEARCH (2007)
Inhibitory activity of stilbenes on Alzheimer's β-amyloid fibrils in vitro
Celine Riviere et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2007)
Role of the toll-like receptor 4 in neuro-inflammation in Alzheimer's disease
Silke Walter et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2007)
Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α
Marie Lagouge et al.
CELL (2006)
Moderate consumption of Cabernet Sauvignon attenuates Aβ neuropathology in a mouse model of Alzheimer's disease
Jun Wang et al.
FASEB JOURNAL (2006)
Suppression of MyD88- and TRIF-dependent signaling pathways of toll-like receptor by (-)-epigallocatechin-3-gallate, a polyphenol component of green tea
Hyung S. Youn et al.
BIOCHEMICAL PHARMACOLOGY (2006)
Activation of toll-like receptor 2 on microglia promotes cell uptake of Alzheimer disease-associated amyloid β peptide
KQ Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Blockade of nuclear factor-kappa B signaling pathway and anti-inflammatory activity of cardamomin, a chalcone analog from Alpinia conchigera
JH Lee et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: A review of their intracellular targets
Charles Ramassamy
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
SIRT1 protects against microglia-dependent amyloid-β toxicity through inhibiting NF-κB signaling
J Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
TAK1, but not TAB1 or TAB2, plays an essential role in multiple signaling pathways in vivo
JH Shim et al.
GENES & DEVELOPMENT (2005)
Resveratrol promotes clearance of Alzheimer's disease amyloid-β peptides
P Marambaud et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: Molecular targets are TBK1 and RIP1 in TRIF complex
HS Youn et al.
JOURNAL OF IMMUNOLOGY (2005)
LPS receptor (CD14): a receptor for phagocytosis of Alzheimer's amyloid peptide
Y Liu et al.
BRAIN (2005)
Mechanism of human SIRT1 activation by resveratrol
MT Borra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Substrate-specific activation of sirtuins by resveratrol
M Kaeberlein et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Genetic and molecular aspects of Alzheimer's disease shed light on new mechanisms of transcriptional regulation
P Marambaud et al.
GENES BRAIN AND BEHAVIOR (2005)
Inflammatory cytokine levels correlate with amyloid load in transgenic mouse models of Alzheimer's disease
Nikunj S. Patel et al.
JOURNAL OF NEUROINFLAMMATION (2005)
Alcohol intake and risk of dementia
JA Luchsinger et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2004)
Neuroprotective effects of resveratrol against β-amyloid-induced neurotoxicity in rat hippocampal neurons:: involvement of protein kinase C
YS Han et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Mutant presenilins specifically elevate the levels of the 42 residue β-amyloid peptide in vivo:: evidence for augmentation of a 42-specific γ secretase
JL Jankowsky et al.
HUMAN MOLECULAR GENETICS (2004)
Lipid A antagonist, lipid IVa, is distinct from lipid A in interaction with Toll-like receptor 4 (TLR4)-MD-2 and ligand-induced TLR4 oligomerization
S Saitoh et al.
INTERNATIONAL IMMUNOLOGY (2004)
Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro:: implications for the prevention and therapeutics of Alzheimer's disease
K Ono et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
KT Howitz et al.
NATURE (2003)
Triggering the interferon antiviral response through an IKK-related pathway
S Sharma et al.
SCIENCE (2003)
IKKε and TBK1 are essential components of the IRF3 signaling pathway
KA Fitzgerald et al.
NATURE IMMUNOLOGY (2003)
Protective effect of resveratrol on β-amyloid-induced oxidative PC12 cell death
JH Jang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2003)
TAB2 is essential for prevention of apoptosis in fetal liver but not for interleukin-1 signaling
H Sanjo et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Red wine ingredient resveratrol protects from beta-amyloid neurotoxicity
E Savaskan et al.
GERONTOLOGY (2003)
Integrin-nucleated Toll-like receptor (TLR) dimerization reveals subcellular targeting of TLRs and distinct mechanisms of TLR4 activation and signaling
HF Zhang et al.
FEBS LETTERS (2002)
Amount and type of alcohol and risk of dementia -: The Copenhagen City Heart Study
T Truelsen et al.
NEUROLOGY (2002)
Intracellular signaling in M-CSF-induced microglia activation: Role of Iba1
Y Imai et al.
GLIA (2002)
Risk factors for Alzheimer's disease:: A prospective analysis from the Canadian Study of Health and Aging
J Lindsay et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2002)
Inflammation in neurodegenerative disease - A double-edged sword
T Wyss-Coray et al.
NEURON (2002)
TAK1 is a ubiquitin-dependent kinase of MKK and IKK
C Wang et al.
NATURE (2001)
Lipopolysaccharide activates Akt in human alveolar macrophages resulting in nuclear accumulation and transcriptional activity of β-catenin
MM Monick et al.
JOURNAL OF IMMUNOLOGY (2001)
A beta-Induce inflammatory processes in microglia cells of APP23 transgenic mice
KD Bornemann et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
Murine TOLL-like receptor 4 confers lipopolysaccharide responsiveness as determined by activation of NFκB and expression of the inducible cyclooxygenase
SH Rhee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Tau protein isoforms, phosphorylation and role in neurodegenerative disorders
L Buée et al.
BRAIN RESEARCH REVIEWS (2000)
Inflammation and Alzheimer's disease
H Akiyama et al.
NEUROBIOLOGY OF AGING (2000)
Minireview -: Biological effects of resveratrol
L Frémont
LIFE SCIENCES (2000)
Share Paper
